Your Thyroid Problem Is Actually A Conversion Problem

Your thyroid makes a hormone called T4, which is mostly inactive. It is a storage form, like a package that has not been opened yet. For that hormone to actually do anything inside your cells, your body has to convert it into something called T3, which is the active version that binds to receptors and drives metabolism, body temperature, heart rate, and energy production.

That conversion does not happen in your thyroid. It happens in your liver, your kidneys, and your skeletal muscle, through a family of enzymes called deiodinases, which work by removing one iodine atom from T4 to produce usable T3. Between 70 and 90 percent of the T3 circulating in your body right now was made this way, in peripheral tissue, not in your gland.

That is the whole system. And once you understand it, the standard approach to diagnosing and treating thyroid problems starts to look incomplete.

Most doctors order a single test called TSH, which stands for thyroid stimulating hormone and is produced by your pituitary gland. The logic is that if your pituitary is sending out normal levels of TSH, your thyroid must be producing enough T4, so everything must be fine. But TSH only tells you about the first half of the chain. It tells you nothing about whether the T4 your thyroid is releasing is actually getting converted into active T3 in your tissues.

One study published in PLoS ONE looked at people who had their thyroid removed entirely and were taking a standard T4 replacement medication called levothyroxine. Even with TSH in the normal range, more than 20 percent of those patients still had abnormal free T3 or free T4 levels when those numbers were directly measured. Their TSH looked fine. Their conversion did not.

This is why the tests you run matter. Free T3 and free T4 measure what is actually available in your blood. Reverse T3 measures an inactive form of the hormone that your body produces when it is under stress and wants to slow things down, essentially a brake on your metabolism. Running only TSH and stopping there tells you the factory is receiving orders. It does not tell you whether the workers are showing up.

So what breaks conversion? There are a few major ones.

Selenium is required for the deiodinase enzymes to function. Without enough of it, those enzymes cannot do their job efficiently, and T4 builds up while T3 drops. Chronic stress elevates cortisol, and elevated cortisol shifts the body toward producing more reverse T3 instead of active T3, because the stress response prioritizes short term survival over long term metabolic output. Low protein intake limits the raw material available for thyroid hormone transport proteins and overall enzyme function. And low muscle mass reduces the surface area where conversion can happen at all, because skeletal muscle is one of the primary sites for a type of deiodinase called D2, which is responsible for local T3 production inside muscle cells.

That last one is worth sitting with. The more lean muscle mass you carry, the more enzymatic machinery your body has available to produce active thyroid hormone where it is actually needed. This is part of why resistance training keeps showing up as a meaningful variable in thyroid health outcomes, and not just for the usual reasons about metabolism.

A 2025 cross sectional study found that recreational exercise was associated with reduced inflammatory markers in patients with Hashimoto's thyroiditis, which is an autoimmune condition where the immune system attacks the thyroid gland. The mechanism here is not just about burning calories. Exercise reduces systemic inflammation, and inflammation is one of the things that suppresses conversion efficiency and drives reverse T3 production.

Protein works through a similar indirect channel. A 2025 case report documented a patient with Hashimoto's whose symptoms resolved after being placed on a structured high protein dietary protocol, without changing her medication. That is one patient and one report, so the evidence is limited and should not be overgeneralized, but the mechanism is plausible: protein supports enzyme function, reduces the stress signals that impair conversion, and maintains the muscle tissue that serves as a conversion site.

If you are eating low protein, training rarely, sleeping poorly, and running on high cortisol, your thyroid can be producing perfectly normal amounts of T4 and you can still have all the symptoms of low thyroid because the downstream conversion is failing. Adding more T4 medication in that scenario does not fix the problem. It adds more substrate to a pipeline that is already blocked.

When lifestyle changes are not enough, there is a second lever worth knowing about. Adding a small amount of direct T3, a medication called liothyronine, bypasses the conversion problem entirely by delivering active hormone directly. A 2022 trial published in Frontiers in Endocrinology looked at female hypothyroid patients who still had residual symptoms despite normal TSH on levothyroxine. Adding T3 to their protocol improved quality of life scores significantly compared to T4 alone. The conversion bottleneck still existed, but they were working around it rather than waiting for it to resolve.

The current clinical guidelines from major thyroid associations still recommend TSH as the primary monitoring tool and do not routinely recommend measuring free T3 or reverse T3. That gap between what the guidelines say and what the physiology suggests is exactly what a 2025 opinion piece in Frontiers in Endocrinology called out directly, arguing that the field has been anchored to a TSH and T4 framework established in the 1970s and has not fully updated to account for what we now know about peripheral conversion. It is worth noting that piece is a single author opinion, not a systematic review, but the underlying mechanism it is describing is well supported.

The practical path is this: get the full panel, meaning TSH plus free T3, free T4, and reverse T3. Build muscle and train consistently. Eat enough protein to support enzyme and tissue function. Manage sleep and cortisol. These are not soft lifestyle suggestions that exist alongside the real treatment. They are the actual mechanism by which your body produces active thyroid hormone.

The thyroid does not run the show alone. It makes a raw material and ships it out. What happens to that material after it leaves depends entirely on the state of your liver, your kidneys, your muscle mass, and your stress response. That is where the problem usually lives, and that is where the solution has to start.

---

References

1. Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R. (2011). Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients. PLoS ONE 6(8):e22552. PMC3148220.
2. Cited for: the >20% of patients with abnormal FT3 or FT4 despite normal TSH on levothyroxine.
3. Limbaugh SL, Ennessy LA, Davis KS, Allen VT. (2025). Nutrition Based, High Protein Adjunct Therapy for Hashimoto's Thyroiditis: A Case Report. Cureus 17(9):e91597. PMC12495900.
4. Cited for: protein protocol resolving Hashimoto's symptoms.
5. Vuletić M, Žnidar V, Barić Žižić A, et al. (2025). Recreational Exercise and Inflammatory Patterns in Hashimoto's Thyroiditis: Observations from a Cross Sectional Study. Biomolecules 15(11):1510. PMC12650045.
6. Cited for: exercise reducing inflammatory markers in Hashimoto's patients.
7. Bjerkreim BA, Hammerstad SS, Gulseth HL, et al. (2022). Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy. Frontiers in Endocrinology 13:816566. PMC8902821.
8. Cited for: clinical evidence that adding T3 improves quality of life in patients with residual symptoms.
9. Lindner HH. (2025). Clinical thyroidology: beyond the 1970s' TSH T4 Paradigm. Frontiers in Endocrinology 16:1529791. PMC12234311.
10. Cited for: critique of the TSH only diagnostic model. Note: single author opinion piece.
11. European Thyroid Journal. Role of hepatic deiodinases in thyroid hormone homeostasis. PMC10160546.
12. Cited for: D1 distribution in liver and kidney, D2 distribution in skeletal muscle.
13. ScienceDirect Topics. Thyroxine Deiodinase.
14. Cited for: the 70-90 percent peripheral conversion figure.
15. Pituitary Foundation. Hormone Replacement Medication Interactions.
16. Cited for: thyroid hormone status affecting IGF-1 levels.
17. American Thyroid Association Guidelines on Treatment of Hypothyroidism.
18. Cited for: current guideline recommending TSH for monitoring without routine FT3 or rT3 testing.

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness